Top compounds associated with response to RFPL3


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.084 0.02
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.12 0.02
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA prochlorperazine CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Methotrexate FIMM pan-cancer AAC -0.29 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA erastin CTRPv2 pan-cancer AAC -0.078 0.03
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV